Exelixis
EXEL
#1759
Rank
A$17.00 B
Marketcap
A$65.46
Share price
2.09%
Change (1 day)
14.22%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company